Inhibition of glycine transporter-1 reduces cue-induced nicotine-seeking, but does not promote extinction of conditioned nicotine cue responding in the rat

Addict Biol. 2013 Sep;18(5):800-11. doi: 10.1111/adb.12049. Epub 2013 Mar 14.

Abstract

Pharmacological stimulation of N-methyl-D-aspartate receptors (NMDAr) could enhance the outcome of cue-exposure therapy for smoking cessation. NMDAr stimulation can be achieved by increasing pharmacologically the synaptic levels of glycine, a necessary co-agonist. Here, we evaluate the effects of SSR504734, a selective inhibitor of glycine type I transporter (GlyT1) in an extinction-reinstatement procedure inducing robust and lasting nicotine-seeking behavior in rats. Male Wistar rats were trained to associate discriminative stimuli (S(D)s) with the availability of nicotine (0.03 mg/kg/65 μL/2 second/infusion) or sucrose (45-mg pellet) versus non-reward in two-lever operant cages. Reinforced response was followed by cue signaling 20-second time-out (CSs). Once the training criterion was met, rats underwent extinction of lever presses, in the absence of reinforcers, S(D) s and CSs. Re-exposure to nicotine or sucrose S(D+)/CS(+), but not non-reward S(D-)/CS(-), revived responding at the previously reinforced lever. Acute pre-treatment with SSR504734 (10 mg/kg i.p.) reduced nicotine-seeking but not sucrose-seeking behavior without influencing rats' locomotor activity. Sub-chronic treatment (10 mg/kg i.p. for 5 days) during daily exposure to S(D+)/CS(+) reduced nicotine-seeking; however, this effect was transient, with return to S(D+)/CS(+) responding at 72 hours. Full recovery to S(D+)/CS(+) responding was observed after 1 month suggesting that SSR504734 sub-acute treatment did not engage the long-term plasticity mechanisms probably involved in nicotine-seeking. In conclusion, GlyT1-inhibitors might offer a therapeutic opportunity for acute cue-controlled nicotine-seeking, but the lack of persistent effects of the sub-chronic treatment associated with nicotine cues exposure suggests that short-term administration of GlyT1-inhibitor SSR504734 is not sufficient to promote extinction of nicotine-cue conditioned responding.

Keywords: Drug-associated cues; GlyT1-inhibitors; nicotine-seeking behavior.

MeSH terms

  • Analysis of Variance
  • Animals
  • Benzamides / administration & dosage
  • Benzamides / pharmacology*
  • Conditioning, Psychological / drug effects*
  • Cues
  • Discrimination Learning / drug effects
  • Dose-Response Relationship, Drug
  • Drug-Seeking Behavior / drug effects*
  • Extinction, Psychological / drug effects*
  • Glycine Plasma Membrane Transport Proteins / antagonists & inhibitors*
  • Implosive Therapy
  • Male
  • Motor Activity / drug effects
  • Nicotine*
  • Piperidines / administration & dosage
  • Piperidines / pharmacology*
  • Random Allocation
  • Rats
  • Rats, Wistar
  • Receptors, N-Methyl-D-Aspartate / agonists
  • Self Administration
  • Sucrose / administration & dosage

Substances

  • 2-chloro-N-((S)-phenyl((2S)-piperidin-2-yl)methyl)-3-trifluoromethyl benzamide
  • Benzamides
  • Glycine Plasma Membrane Transport Proteins
  • Piperidines
  • Receptors, N-Methyl-D-Aspartate
  • Slc6a9 protein, rat
  • Sucrose
  • Nicotine